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ABSTRACT
Objective: The current study aimed at the investigation of the effectiveness of ethanolic and methanolic extract of Polygonum glabrum in aluminum 
chloride-induced Alzheimer’s disease in experimental rats.
Methods: The behavioral parameters evaluated by following methods such as Morris water maze test, radial arm maze test, and active avoidance test. 
Biochemical parameters were also estimated such as acetylcholine and acetylcholine esterase.
Results: Polygonum glabrum extract was instituted to be neuroprotective against AlCl3-induced toxicity. Enhanced learning and memory were allied 
to the ingestion of extract in rats. Al overload, acetylcholinesterase enzyme hyperactivity is responsible for Alzheimer’s disease which is neutralized or 
reduced with treatment of extract, which might be due to the synergistic action of its active constituents. Ethanolic extract was shown slightly higher 
efficacy as compared to methanolic extract.
Conclusion: Based on these current findings, it is suggested that lowering Aβ is an unproven strategy, and it may be time to refocus on other targets 
for the treatment of this disease, including pathological forms of tau.
Keywords: Alzheimer’s disease, beta-amyloid plaque, Aβ peptide.
INTRODUCTION
Alzheimer’s disease is considered to be in responsible of around 60% 
of all mental disorder in older adults or moderately aged [1] and 
influence in more than of 5 million Americans, a number assessed to 
augmentation to 7.7 million by means of 2030.
Alzheimer’s disease is caused because of aggregation of misfolded proteins 
buildup of deposits of fibrillary amyloid in selective areas of the central 
nervous system. Alzheimer’s disease leads in memory loss, unusual 
behavior, personality changes, and loss of the capability to thinking. 
Early disease exhibits short-term memory loss, fail to retain information 
names and addresses, not able to learn novel information, mood swings, 
as the circumstance develops, transform becomes more prominent, and 
persons even forget way to home. Frustration, hostility, and irritability 
are typical emotional features exhibited by means of AD patients. Genetic 
factors are responsible for70% of Alzheimer’s disease and the remaining 
is the environmental factor. Most of the cases of Alzheimer’s disease 
are late age onset; progresses post to an age of 60 [2]. At present, most 
established treatment strategy of Alzheimer’s disease is inhibitors of 
cholinesterase, inactivate acetylcholinesterase enzyme (AChE) to augment 
the acetylcholine levels in brain. Inhibitors of acetylcholinesterase 
comprise drugs such as rivastigmine, tacrine, galantamine, donepezil, and 
memantine. Yet, there is no perfect drug for Alzheimer’s disease treatment, 
besides only relieve the disease symptoms. [3] Herbal medicine gives a 
substitute option to alter symptoms and development of AD.
MATERIALS AND METHODS
Collection of plant material
The aerial parts of plant Polygonum glabrum employed for the current 
in quest was collected from Sri Venkateshwara University, Tirupati, 
India. The plant was authenticated by Dr. Madhava Chetty, Department 
of Botany. Specimen of voucher of the plant P. glabrum was conserved at 
SV institute herbarium library, Tirupati, A.P.
Preparation of ethanolic and methanolic extracts
The aerial parts of fresh and new medicinal plants collected. To get 
relieve of adhered dirt, aerial parts were rinsed and cleaned by means 
of distilled water, subsequently blotted thoroughly and dehydrated 
by means of shade in its consign of sunlight. The shadily dried aerial 
parts were crushed by means of a commercially available mixer. The 
obtained medicinal plant powder was an auxiliary filter to get fine 
powder and engaged for extraction by means of solvents. Almost 100 
g of the crushed plant medicinal aerial parts was kept for Soxhlet 
extraction by means of 1000 ml solvents, ethanol, and methanol. This 
accurate cycle was repetitive again and again, for hours to hardly many 
days, till the color of the solvent washing out away in the siphon of the 
Soxhlet. The extract was resolute under condensed pressure (P) and 
stock up in the refrigerator proceeding to commencing for advanced 
utilizations [4].
Phytochemical component observed in ethanolic and methanolic 
extract of P. glabrum
In-vivo study
The behavioral screening was done by the following methods [5-8].
Morris water maze test
Morris water maze test was performed for assessment of the retention 
of working (as a reference) and spatial memory in Wistar rats. The 
water maze contains of a circular tank (150 cm in diameter and 40 cm 
in height). Water pool was alienated into 4 equally spaced quadrants 
all along the circumference of the pool. A flee platform (10 cm in 
diameter) submerged 2 cm beneath the water surface was positioned 
in NW quadrant. Rats were trained to situate the hidden platform at 
a fixed spot in NW quadrant. All rats were kept to 1 session of 4 trials 
per day. During each trial, the animal was positioned in each quadrant 
to remove quadrant effects. All rats were left in the platform for 30 
seconds and then removed and dried using a towel [9]. Rats failing to 
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locate the platform within 60 s were directed to the platform. Twenty-
four-hour after previous training, escape platform was taken away and 
probe trial was conducted. The cutoff time for animal to swim was set 
to at 60 s before the finish of the session. Time elapsed in escaping to 
the NW quadrant, that is, escape latency time was measured all through 
the trials of retention.
Radial arm maze test
Radial arm maze is a significant tool for the study of spatial memory 
in rats. It was employed as being described by Olton (1976) with 
minor modifications to assess spatial memory deficit in rats. The 
maze employed is 122 cm in diameter. It contains 8 chambers and 
each chamber is 46 cm in length from the center, 16.5 cm in wide, and 
its walls are 37.5 cm in height. The inner arena is 31 cm in diameter. 
Animals were kept overnight fasting prior to the test. At the start of the 
test, each animal was free in the center of the maze facing the baited 
arm and was permitted to explore the maze liberally in the 1st day; not 
a single record was taken [10]. On a week basis, rats are released in 
the center of the maze facing the baited arm and set a maximum 6 min 
to locate the food. If 1 animal found the food before the finish of time, 
then the watch was stopped and elapsed time is registered. Numbers of 
entry to the right arm and the wrong arms were as well recorded for a 
week basis.
Active avoidance (AA) test
Measurements of AA responses were achieved by means of utilizing 
spaced trials behavioral procedural methods (20-trial sessions daily 
for every week). A conventional 2-way AA schedule was employed with 
trials starting at 30 s intervals time. Each trial begins with an accustomed 
signal (CS) (broadband noise of 68 dB lasting 7 s), followed by an 
unconditioned stimulus (US) (foot shock of 1.5 mA, 3 s time duration) 
distributed through the floor grids. Passage responses through the 
conditioned stimulus (AA response) ended the conditioned stimulus 
and not permitted the beginning of unconditioned stimuli  [11]. A reply 
after the onset of an escape response (unconditioned stimulus) ended 
both conditioned and unconditioned stimuli.
For each behavioral screening model, the animals were divided into 6 
groups. Each group constitutes six animals. The study was approved by 
the Institutional Animal Ethical Committee (IAEC) with approval no. 
03/IAEC/NCPA/M.Pharmacy 19–20.
All the three models carried out for ethanol and methanol extracts 
separately.
Biochemical analysis
The brain extract of both models was assayed for acetylcholine and 
acetylcholine esterase using standard protocol methods. Forebrain 
cortex and striatum were dissected by means of bilaterally from each 
frozen brain and crude mitochondrial portion was prepared from 
each region as previously illustrated methods. The determination 
of acetylcholine esterase activity was based on the degradation 
of acetyl thiocholine iodide by action of AchE into a subsequent 
Fig. 1: Morris water maze test
Fig. 2: Radial arm maze test
Fig. 3: Active avoidance test product ultimately binds to5, 5-dithiobis-2-nitrobezoic acid, 
Fig. 4: Effect of ethanolic extract of Polygonum glabrum effectiveness on escape latency time made by means of Morris water maze test
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resulting in a yellow color [12]. Kinetics of the enzymatic reactions 
was followed over 3–5 min time at 412 nm wavelength. Values of 
AchE activity were deduced from the linear portion of the reaction 
curve and were expressed as units mmol acetyl thiocholine/min/g 
prot. The protein amount in the rat brain homogenates (forebrain 
cortex and striatum, ipsi- and contra-lateral regions) was measured 
by the Lowry method by means of bovine serum albumin as the 
reference standard.
Statistical analysis of data
Results were characterized as mean±S.E.M. The statistical variation 
amid the groups was computed in the characteristic of ANOVA with 
mean±S.E.M. The discrepancy was considered significant if p<0.05.
RESULTS
Percentage yield of ethanolic and methanolic extract of Polygonum 
glabrum
The Acute toxicity valuation performed on animal sex posed that the 
Polygonum glabrum Methanolic and ethanolic extract was in safe 
and sound even at amount of 2 gram/kgb.w. The reasonably accurate 
and precise LD 50 is may possibly is >2 gram/kg b.w. And hitherto 
supplementary not any lethality or any class of toxic retort and or 
moribund class of state was observed till the finish of the extent of 
investigational research.
Phytochemical component observed in ethanolic and methanolic 
extract of Polygonum glabrum
Data represented as mean±S.E.M values of 6 animals each. *p<0.05, 
**p<0.01 (Dunnett t-test); control was compared with extract and 
standard treated groups were compared.
In relevant case of the of ethanolic and methanolic extract of Polygonum 
glabrum effectiveness on time lapse by means of radial arm maze test, 
the ethanolic and methanolic extract exposed considerably decline 
in time lapse. Ethanolic extract is more effective as comparison with 
methanolic extract.
DISCUSSION
Results obtained from water maze test demonstrated a dependable 
lessen in the time required to find the platform. The aluminum-treated 
rats showed high fluctuation in the time required to reach the platform 
from 1 day to another (Tables 1-4). The declining rate of the time 
needed to reach the platform was relatively steady for the control, 
standard, and group treated with extracts. These outcomes guide us to 
Table 1: For ethanol, extract grouping is as follows
Group 1: Normal group (Tween 80)
Group 2: Disease control group-aluminum chloride (300 mg/kg, P.O.)
Group 3: Standard-rivastigmine (0.3 mg/kg, I.P.) + aluminum 
chloride (300 mg/kg, P.O.)
Group 4: Test-I-Polygonum glabrum 100 mg/kg + aluminum chloride 
(300 mg/kg, P.O.)
Group 5: Test II-Polygonum glabrum 200 mg/kg + aluminum chloride 
(300 mg/kg, P.O.)
Group 6: Test III-Polygonum glabrum 400 mg/kg + aluminum 
chloride (300 mg/kg, P.O.)
The study duration is 20 days
Table 2: For methanol, extract grouping is as follows
Group 1: Normal group (Tween 80)
Group 2: Disease control group-aluminum chloride (300 mg/kg, P.O.)
Group 3: Standard-rivastigmine (0.3 mg/kg, I.P.) + aluminum 
chloride (300 mg/kg, P.O.)
Group 4: Test-I-Polygonum glabrum 100 mg/kg + aluminum chloride 
(300 mg/kg, P.O.)
Group 5: Test II-Polygonum glabrum 200 mg/kg + aluminum chloride 
(300 mg/kg, P.O.)
Group 6: Test III-Polygonum glabrum 400 mg/kg + aluminum 
chloride (300 mg/kg, P.O.)
The study duration is 20 days
Table 4: Particulars of qualitative phytochemical assessment





Mayer’s test + +
Dragondraff’s test + +
Hager’s test + +
Wagner’s test + +
2 Carbohydrates
Mohlish’s test + +
3 Reducing sugars
Fehling’s test + +
Benedicts test + +
4 Saponins
Foam test − −
Forth test − −
5 Phytosterols
Salkowski test + +
Liebermann–Burchard’s test + +
6 Phenolics
Ferric chloride test − −
Lead acetate test − −
7 Tannins
Ferric chloride test + +
8 Flavones and flavonoids
Lead acetate test + +
Alkaline reagent test − +
9 Glycosides
Keller–Killiani test + +
10 Proteins and amino acids
Ninhydrin test + +
Biuret test + +
11 Terpenoids
Salkowski’s test − −
12 Fixed oils and fats
Spot test − −
Saponification test − −
13 Gum and mucilages
Ruthenium red solution + +
+: Positive, −: Negative
Table 3: Percentage yields of extracts
S. No Solvent Percentage yield
1. Ethanol 12.4
2. Methanol 10.5
Table 5: Effect of ethanolic extract of Polygonum glabrum 
effectiveness made by means of active avoidance test
Groups Active avoidance
7th day 14th day 21st day
Normal 25±0.31 30±0.43 32±0.59




(Rivastigmine 0.3 mg/kg I.P.)
EPG (100 mg/kg) 18±0.48 20±0.65 23±0.51
EPG (200 mg/kg) 20±0.33 22±0.49 26±0.46
EPG (400 mg/kg) 22±0.57 24±0.59 28±0.63
23±0.44 26±0.61 30±0.72***
Data represented as mean±S.E.M values of 6 animals each. *p<0.05, **p<0.01 
(Dunnett’s t-test); control was compared with extract and standard treated 
groups were compared
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Fig. 5: Effect of methanolic extract of Polygonum glabrum effectiveness on escape latency time made by means of Morris water maze test
Fig. 6: Effect of ethanolic extract of Polygonum glabrum effectiveness on time-lapse made by means of radial arm maze test
Fig. 7: Effect of methanolic extract of Polygonum glabrum effectiveness on time-lapse made by means of radial arm maze test
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Table 7: Effect of methanolic extract of Polygonum glabrum 
effectiveness made by means of active avoidance test
Groups Active avoidance
7th day 14th day 21st day
Normal 24±0.46 28±0.39 30± 0.61
Disease control  
(AlCl3 300 mg/kg)
15±0.24 11±0.41 6 ± 0.32
Standard  
(Rivastigmine 0.3 mg/kg I.P.)
MPG (100 mg/kg) 16±0.56 18±0.72 21±0.49
MPG (200 mg/kg) 18±0.66 20±0.51 24±0.57
MPG (400 mg/kg) 20±0.63 22±0.54 26±0.61
guesstimate that extract may exert its effect by means of managing the 
lessening rate of time. The fluctuation in the time required to find the 
platform showed by means of AlCl3-treated rats was lessened by means 
of the ingestion of PG (Table 5). Suggesting that, although the effect of 
PG was not revealed by means of monitoring the time needed to find 
the platform, yet, it was demonstrated that PG effect was resulted to 
the waning rate in the time and reverting the fluctuation produced by 
means of AlCl3 (Table 6). A high correlation was found between the 
Table 6: Effect of ethanolic extract of Polygonum glabrum 
effectiveness on escape latency time made by means of Morris 
water maze test
Groups Escape latency time (s)
7th day 14th day 21st day
Normal 4.85±0.37 5.23±0.29 5.34±0.68







EPG (100 mg/kg) 4.97±0.60 13.54±0.32 10.22±0.89***
EPG (200 mg/kg) 4.91±0.34 12.98±0.38 9.43±0.63***
EPG (400 mg/kg) 4.89±0.29 12.12±0.27 7.84 ± 0.57***
Fig. 8: Effect of ethanolic extract of Polygonum glabrum effectiveness made by means of active avoidance test
Fig. 9: Effect of methanolic extract of Polygonum glabrum effectiveness made by means of active avoidance test
21±0.42 23±0.66 28±0.48***
Data represented as mean±S.E.M values of 6 animals each. *p<0.05, **p<0.01 
(Dunnett’s t-test); control was compared with extract and standard treated 
groups were compared
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radial maze test and the avoidance response in PG-treated groups. The 
correlations specify that both radial arm maze and AA test possibly will 
assess memory dispensation in a definite region of rat’s brain.  A part of 
model of AA, demonstrated 2-fold lessening correct reactions from the 
7th to the 21st day of assessment in AlCl3-treated animals as compared 
with the group of control (Tables 4, 7 and 8).
Aluminum provokes stable and reproducible depression of AA 
response, meaning Al damages rat cognitive functioning (Table 1). 
These consequences, all along with the obtained decreased AchE 
activity, suggest that Al exerts its toxic effects by altering transmission 
of cholinergic eventually imitated in neurobehavioral deficits [15] as 
shown in Tables 5,6,9-12. Aluminum is not only a selective cholinergic 
neurotoxin and possibly will also affect non-cholinergic neurons 
concerned in spatial learning. Earlier studies have exposed that 
attention and spatial learning were disturb in the Al-treated rats [16,17]. 
The AD rats as well shown a significant lessen in Ach levels along with 
an elevation in AchE activity (Table 7). Rivastigmine was used as a 
standardized drug as it is the only proven pharmacological therapy 
for the symptomatic treatment of AD [18]. Treatment of AD rats with 
rivastigmine as a protective or therapeutic agent led to an improvement 
in the oxidative stress status, as represented by a significant increase in 
the levels of activity in the activity cages and brain Ach levels as well as 
a significant decrease in the results of the radial arm maze and brain 
AchE levels when compared with the AD-induced groups of rats [19,20].
Table 8: Effect of methanolic extract of Polygonum glabrum 
effectiveness on escape latency time made by means of Morris 
water maze test
Groups Escape latency time (s)
7th day 14th day 21st day
Normal 4.87±0.34 5.12±0.27 5.47±0.63




MPG (100mg/kg) 5.12±0.65 14.72±0.39 11.37±0.77***
MPG (200 mg/kg) 4.93±0.39 13.59±0.37 10.12±0.54***
MPG (400 mg/kg) 4.91±0.34 12.82±0.52 8.45 ± 0.68***
Table 9: Effect of ethanolic extract of Polygonum glabrum effectiveness acetylcholine and acetylcholinesterase levels
Groups Acetylcholine (µmol/mg protein) Acetylcholinesterase enzyme (unit/mg protein)
Normal 5.65±0.15 0.54±0.04
Disease control (AlCl3 300 mg/kg) 0.87±0.05 0.82±0.02
Standard (rivastigmine 0.3 mg/kg I.P.) 5.4±0.17 0.56±0.03
EPG (100 mg/kg) 2.7±0.23 0.75±0.05
EPG (200 mg/kg) 3.4±0.21 0.63±0.04
EPG (400 mg/kg) 4.9±0.29 0.59±0.06
Table 10: Effect of methanolic extract of Polygonum glabrum effectiveness acetylcholine and acetylcholine esterase levels
Groups Acetylcholine (µmol/mg protein) Acetylcholinesterase enzyme (unit/mg protein)
Normal 5.59±0.12 0.57±0.05
Disease control (AlCl3 300 mg/kg) 0.85±0.03 0.85±0.03
Standard (rivastigmine 0.3 mg/kg I.P.) 5.37±0.17 0.58±0.02
MPG (100 mg/kg) 2.5±0.2 0.77±0.06
MPG (200 mg/kg) 3.2±0.18 0.66±0.03




Data represented as mean±S.E.M values of 6 animals each. *p<0.05, **p<0.01 
(Dunnett’s t-test); control was compared with extract and standard treated 
groups were compared
Data represented as mean±S.E.M values of 6 animals each. *p<0.05, **p<0.01 (Dunnett’s t-test); control was compared with extract and standard treated groups were 
compared
Fig. 10: Effect of ethanolic extract of Polygonum glabrum effectiveness acetylcholine and acetylcholine esterase levels
124
Asian J Pharm Clin Res, Vol 14, Issue 1, 2021, 118-125
 Suneesha and Kumar
CONCLUSION
P. glabrum extract was instituted to be neuroprotective against AlCl3-
induced toxicity. Enhanced learning and memory were allied to 
the ingestion of extract in rats. Al overload, AChE hyperactivity is 
responsible for Alzheimer’s disease which is neutralized or reduced 
with treatment of extract, which might be due to the synergistic 
action of its active constituents. Ethanolic extract was shown slightly 
higher efficacy as compared to methanolic extract. However, extensive 
research is needed to validate the anti-Alzheimer effect of extract active 
components against a variety of models of AD before entering into the 
clinical trials.
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